Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Real-time and wireless assessment of adherence to antiretroviral therapy with co-encapsulated ingestion sensor in HIV-infected patients: A pilot study.

Daar ES, Wang Y, Siqueiros L, Shen J, Guerrero M, Di X, Dao J, Young T, Corado K, Fletcher CV, Liu H.

Clin Transl Sci. 2019 Sep 19. doi: 10.1111/cts.12701. [Epub ahead of print]

PMID:
31536156
2.

Recent HIV Risk Behavior and Partnership Type Predict HIV Pre-Exposure Prophylaxis Adherence in Men Who Have Sex with Men.

Blumenthal J, Moore DJ, Jain S, Sun X, Ellorin E, Corado K, Hoenigl M, Dube M, Haubrich R, Morris SR.

AIDS Patient Care STDS. 2019 May;33(5):220-226. doi: 10.1089/apc.2018.0289.

PMID:
31067122
3.

Effect of Vitamin D Supplementation on Bone Turnover Markers During HIV Pre-Exposure Prophylaxis Using Tenofovir Disoproxil Fumarate-Emtricitabine in Men Who Have Sex with Men.

Nanayakkara DD, Sun X, Morris S, Louie S, Mulligan K, Overton T, Asante I, Corado K, Jain S, Dubé MP.

AIDS Res Hum Retroviruses. 2019 Jul;35(7):608-614. doi: 10.1089/AID.2018.0280. Epub 2019 May 8.

PMID:
30907095
4.

Predictors of Long-Term HIV Pre-exposure Prophylaxis Adherence After Study Participation in Men Who Have Sex With Men.

Hoenigl M, Hassan A, Moore DJ, Anderson PL, Corado K, Dubé MP, Ellorin EE, Blumenthal J, Morris SR; California Collaborative Treatment Group (CCTG) 601 Team.

J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):166-174. doi: 10.1097/QAI.0000000000002003.

PMID:
30865175
5.

Two-drug regimens for treatment of naïve HIV-1 infection and as maintenance therapy.

Corado KC, Caplan MR, Daar ES.

Drug Des Devel Ther. 2018 Nov 1;12:3731-3740. doi: 10.2147/DDDT.S140767. eCollection 2018. Review.

6.

Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men1.

Hoenigl M, Jain S, Moore D, Collins D, Sun X, Anderson PL, Corado K, Blumenthal JS, Daar ES, Milam J, Dubé MP, Morris S; California Collaborative Treatment Group 595 Team.

Emerg Infect Dis. 2018 Dec;24(12). doi: 10.3201/eid2412.180400.

7.

Sexual Risk Compensation in a Pre-exposure Prophylaxis Demonstration Study Among Individuals at Risk of HIV.

Milam J, Jain S, Dubé MP, Daar ES, Sun X, Corado K, Ellorin E, Blumenthal J, Haubrich R, Moore DJ, Morris SR; CCTG Team.

J Acquir Immune Defic Syndr. 2019 Jan 1;80(1):e9-e13. doi: 10.1097/QAI.0000000000001885.

PMID:
30334877
8.

Trajectories and Predictors of Longitudinal Preexposure Prophylaxis Adherence Among Men Who Have Sex With Men.

Pasipanodya EC, Jain S, Sun X, Blumenthal J, Ellorin E, Corado K, Dube MP, Daar ES, Morris SR, Moore DJ; California Collaborative Treatment Group (CCTG) TAPIR Study Team.

J Infect Dis. 2018 Oct 5;218(10):1551-1559. doi: 10.1093/infdis/jiy368.

PMID:
30295803
9.

Effect of rectal douching/enema on rectal gonorrhoea and chlamydia among a cohort of men who have sex with men on HIV pre-exposure prophylaxis.

Hassan A, Blumenthal JS, Dube MP, Ellorin E, Corado K, Moore DJ, Morris SR.

Sex Transm Infect. 2018 Nov;94(7):508-514. doi: 10.1136/sextrans-2017-053484. Epub 2018 Jun 15.

PMID:
29907624
10.

Randomized Trial of a Health Coaching Intervention to Enhance Retention in Care: California Collaborative Treatment Group 594.

Corado K, Jain S, Morris S, Dube MP, Daar ES, He F, Aldous JL, Sitapati A, Haubrich R, Milam J, Karris MY.

AIDS Behav. 2018 Aug;22(8):2698-2710. doi: 10.1007/s10461-018-2132-3.

11.

Next generation fixed dose combination pharmacotherapies for treating HIV.

Caplan MR, Daar ES, Corado KC.

Expert Opin Pharmacother. 2018 Apr;19(6):589-596. doi: 10.1080/14656566.2018.1450866. Epub 2018 Mar 20. Review.

PMID:
29557204
12.

Randomized Controlled Trial of Daily Text Messages to Support Adherence to Preexposure Prophylaxis in Individuals at Risk for Human Immunodeficiency Virus: The TAPIR Study.

Moore DJ, Jain S, Dubé MP, Daar ES, Sun X, Young J, Corado K, Ellorin E, Milam J, Collins D, Blumenthal J, Best BM, Anderson P, Haubrich R, Morris SR.

Clin Infect Dis. 2018 May 2;66(10):1566-1572. doi: 10.1093/cid/cix1055.

13.

Tenofovir Disoproxil Fumarate-Associated Fanconi Syndrome in an Human Immunodeficiency Virus (HIV)-Uninfected Man Receiving HIV Pre-Exposure Prophylaxis.

Khan S, Funk CA, Corado K, Morris S, Dube MP.

Open Forum Infect Dis. 2017 Jul 22;4(3):ofx149. doi: 10.1093/ofid/ofx149. eCollection 2017 Summer. No abstract available.

14.

Emtricitabine + tenofovir alafenamide for the treatment of HIV.

Corado KC, Daar ES.

Expert Opin Pharmacother. 2017 Mar;18(4):427-432. doi: 10.1080/14656566.2017.1288720. Epub 2017 Feb 8. Review.

PMID:
28151023
15.

Condomless Sex With Virologically Suppressed HIV-Infected Individuals: How Safe Is It?

Daar ES, Corado K.

JAMA. 2016 Jul 12;316(2):149-51. doi: 10.1001/jama.2016.5636. No abstract available.

PMID:
27404181

Supplemental Content

Loading ...
Support Center